| Giovanni Caforio |
Executive Chair of the Board, Director |
$26.7 M |
|
|
Mar 10, 2024 |
| Sandra Leung |
EVP, General Counsel |
$25.6 M |
|
|
Mar 10, 2024 |
| David V. Elkins |
EVP, Chief Financial Officer |
$12.7 M |
|
|
Mar 10, 2024 |
| Christopher Boerner |
Chief Executive Officer, Director |
$10.8 M |
+$250 K |
+2.38% |
Mar 10, 2024 |
| Samit Hirawat |
EVP,Chief Med.Offr.,Drug Dev. |
$5.43 M |
|
|
Mar 10, 2024 |
| Gerald L. Storch |
Director |
$4.78 M |
|
|
Mar 31, 2024 |
| Rupert Vessey |
EVP & President, Research |
$4 M |
|
|
May 3, 2023 |
| Theodore R. Samuels II |
Director |
$3.83 M |
+$423 K |
+12.4% |
Jun 30, 2024 |
| Paul von Autenried |
EVP, Chief Information Officer |
$3.16 M |
|
|
Nov 22, 2021 |
| Peter J. Arduini |
Director |
$2.25 M |
|
|
Jun 30, 2024 |
| Ann Powell |
EVP, Chief Human Resources |
$2.11 M |
-$1.1 M |
-34.3% |
Aug 24, 2023 |
| Elizabeth Mily |
EVP, Strategy & BD |
$2.06 M |
|
|
Apr 1, 2023 |
| Karin Shanahan |
EVP, Glob. Prod. Dev. & Supply |
$1.93 M |
|
|
Apr 1, 2024 |
| Louis S. Schmukler |
EVP,Pres.,Glob.Prod. & Supply |
$1.59 M |
|
|
May 10, 2021 |
| Gregory Scott Meyers |
EVP, Chief Digital & Tech Off. |
$1.58 M |
|
|
Mar 10, 2024 |
| Robert M. Plenge |
EVP, Chief Research Officer |
$1.54 M |
-$44.8 K |
-2.82% |
Mar 10, 2024 |
| Karen H. Vousden |
Director |
$1.47 M |
|
|
Feb 1, 2024 |
| Julia A. Haller |
Director |
$1.33 M |
|
|
Feb 1, 2024 |
| Michael W. Bonney |
Director |
$1.2 M |
|
|
Jun 30, 2021 |
| R. Phyllis Yale |
Director |
$1.2 M |
|
|
Jun 30, 2024 |
| Cari Gallman |
EVP, Corporate Affairs |
$1.16 M |
|
|
Mar 10, 2024 |
| Karen Murphy Santiago |
SVP & Controller |
$1.11 M |
|
|
Mar 14, 2022 |
| Adam Lenkowsky |
EVP, Chief Commercial Officer |
$1.08 M |
|
|
May 1, 2024 |
| Derica W. Rice |
Director |
$1.03 M |
|
|
Jun 30, 2024 |
| Phil M. Holzer |
SVP and Controller |
$936 K |
|
|
Mar 10, 2024 |
| Paula A. Price |
Director |
$783 K |
|
|
Feb 1, 2024 |
| Amanda Poole |
EVP, Chief Human Resources |
$752 K |
|
|
Mar 10, 2024 |
| Benjamin Hickey |
President, RayzeBio Org. |
$735 K |
|
|
Mar 10, 2024 |
| Adam Dubow |
SVP,ChiefCompliance&EthicsOff. |
$734 K |
|
|
Jul 30, 2021 |
| Michelle Weese |
EVP, Corporate Affairs |
$707 K |
|
|
Jul 1, 2023 |
| Joseph Eid |
SVP,Head Glob. Medical Affairs |
$688 K |
|
|
Jun 3, 2021 |
| Manuel Hidalgo |
Director |
$663 K |
|
|
Feb 1, 2024 |
| Deepak Bhatt |
Director |
$432 K |
|
|
Jun 30, 2024 |
| Lynelle Hoch |
President, Cell Therapy Org. |
$363 K |
|
|
Mar 10, 2024 |
| Sharon Greenlees |
SVP & Controller |
$191 K |
|
|
May 2, 2023 |
| Michael R. McMullen |
Director |
$123 K |
|
|
Jul 1, 2024 |